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EDITORIAL COMMENT
Pacing the Left Ventricle:
Does Underlying Rhythm Matter?*
Angelo Auricchio, MD, PHD
Magdeburg, Germany
Cardiac resynchronization therapy (CRT), a left-sided ven-
tricular pacing therapy for highly symptomatic heart failure
(HF) patients with ventricular conduction delay, is indi-
cated in patients with preserved sinus rhythm (SR) (1). Few
data are available on whether CRT might benefit patients
with chronic atrial fibrillation (AF) after atrioventricular
(AV) junction ablation. The study by Puggioni et al. (2) in
this issue of the Journal helps to define the potential role of
CRT in a pacemaker-dependent AF patient population.
See page 234
Cardiac resynchronization therapy can be delivered either
by simultaneous pacing of the right ventricle (RV) and left
ventricle (LV; commonly referred to as biventricular pacing)
or by pacing the LV alone after sensing or pacing the atrium
at a given AV delay. Both methods can re-time the delayed
ventricle by resynchronizing LV and RV contractions,
resynchronizing regional LV wall motion, and maximizing
preload by shortening the AV delay (3–5). In patients with
SR, biventricular pacing and LV pacing alone improve
short-term systolic pump function to a similar extent (3–6)
and, after short-term treatment, similarly improve the
symptoms, quality of life, and exercise capacity of patients
with severe HF (7).
Atrial fibrillation, a frequent comorbidity in symptomatic
HF patients, can be a challenging arrhythmic disorder to
treat. The long-term management of AF is often unsatis-
factory despite the availability of numerous pharmacologic
and non-pharmacologic therapies. The ability of ablation
and pacing therapy to provide relief to the most highly
symptomatic patients meets a large and growing challenge
in clinical practice. However, recent reports have pointed
out that long-term RV pacing may be responsible for the
onset or aggravation of symptoms of HF after ablation of
the AV junction (8,9). Indeed, RV pacing induces asyn-
chronous activation of the LV, which may mimic the
abnormal activation sequence of left bundle branch block
that is present in most patients currently receiving CRT
(10).
Recognizing this problem, a few studies have tried to
extend CRT to HF patients with AF and AV junction
ablation. The results are mixed. Such patients upgraded
from RV to biventricular pacing exhibited positive clinical
improvement (11). However, the prospective, randomized
Multisite Stimulation in Cardiomyopathies study, which
compared biventricular and RV pacing in this population,
failed to meet its end points with an intention-to-treat
analysis (12).
The study by Puggioni et al. (2) tested the unique
hypothesis that LV pacing alone may be an effective
alternative to chronic RV pacing in pacemaker-dependent
AF patients. They included patients with and without
previous ventricular conduction delay, some presenting with
HF, but many not. All patients had ablation of the AV
junction because of high ventricular rates due to AF. The
study compared the changes in acute ventricular pump
function with LV pacing alone to conventional RV pacing.
The main result was that LV pacing provided a statistically
significant but minor clinical advantage over RV pacing.
Furthermore, rhythm regularization by ablation provided
the main therapeutic benefit, whereas the pacing site played
a minor role by incrementally improving LV systolic func-
tion. It is unfortunate that their study did not also compare
the effects of biventricular pacing because a larger advantage
in that mode is possible in pacemaker-dependent patients.
This can be deduced from the Puggioni et al. (2) results,
first by observing that LV pacing alone would appear to be
much less effective in patients with AF than in patients with
SR, regardless of whether a previous ventricular delay is
present. In patients with ventricular conduction delay and
SR, LV pacing alone usually increases LV systolic function
by around 20% and usually improves systolic function
twofold to threefold more than RV pacing (4). In the AF
patients of the Puggioni et al. study (2), LV pacing
increased ejection fraction only 5.7% more than with RV
pacing. This difference may be explained by the several ways
that underlying rhythm can modulate the effect of ventric-
ular pacing on pump function, including altering preload
and creating an intrinsic activation front conducted through
the AV node. Recent data suggest that the optimal resyn-
chronization for increasing LV contractile function with LV
pacing occurs with a fusion of intrinsic RV activation and
paced LV activation (13,14). Clearly, after ablating the AV
node, intrinsic rhythm is not conducted; thus, fusion is not
possible. In this situation, pre-excitation of only the LV may
create a delayed activation of the septum and RV, which
worsens ventricular pump function, analogous to deficits
generated by RV-only pacing. Therefore, biventricular pac-
ing may be more effective than LV pacing alone in these
patients.
Although the long-term results of the Optimal Pacing
Site (OPSITE) study are eagerly awaited, the question of
whether LV pacing should be considered as a first-line
treatment in patients with AF undergoing ablation of the
AV junction remains unanswered. The short-term data by
Puggioni et al. (2), which showed only minor improvements
with LV pacing versus RV pacing, seem insufficient to
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justify the additional patient risk and difficulty of implanting
an LV-only pacing system. Furthermore, for these patients,
there can be a safety issue with the relatively young
technique of LV-only pacing. After patients have been
made pacemaker-dependent by ablating the AV junction,
the implanted pacing system must be highly reliable and
stable. Although stability and electrical characteristics of the
latest generation of long-term LV pacing leads are markedly
improved, they still are reported to have higher dislocation
rates and higher stimulation thresholds than conventional
RV pacing leads. Thus, safety may be the most important
issue to consider at this time when contemplating the use of
LV pacing alone to deliver CRT in post-ablation patients.
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